<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01256710</url>
  </required_header>
  <id_info>
    <org_study_id>CS-10-012-EU-TV</org_study_id>
    <nct_id>NCT01256710</nct_id>
  </id_info>
  <brief_title>Trifecta Durability Study</brief_title>
  <official_title>Trifecta Durability Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the SJM International, Inc. sponsored &quot;Trifecta™ Durability Study&quot;, is to&#xD;
      evaluate the long-term durability of the Trifecta™ valve.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was terminated approximately 6 months earlier than planned because 227 subjects (59%&#xD;
    more than anticipated) had already completed 10-Year Visits due to lower than expected&#xD;
    attrition&#xD;
  </why_stopped>
  <start_date type="Actual">January 2011</start_date>
  <completion_date type="Actual">March 12, 2021</completion_date>
  <primary_completion_date type="Actual">March 12, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Actuarial freedom from reoperation due to Structural Valve Deterioration</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Actuarial survival rate</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Freedom from valve related death</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Freedom from structural valve deterioration</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">1231</enrollment>
  <condition>Aortic Valve Disorder</condition>
  <arm_group>
    <arm_group_label>Trifecta Valve Group</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of the Trifecta Valve</intervention_name>
    <description>Implantation of the bioprothesis valve, Trifecta Valve</description>
    <arm_group_label>Trifecta Valve Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that are candicate for implantation or have been implanted over the past 9 months&#xD;
        with a St. Jude Medical Trifecta heart valve.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients implanted for less than 9 months, or candidate for implantation with a St&#xD;
             Jude Medical Trifecta valve, as per current guidelines&#xD;
&#xD;
          -  Patient requires aortic valve replacement.&#xD;
&#xD;
          -  Patient is legal age in host country.&#xD;
&#xD;
          -  Patients must be able and willing to provide written informed consent to participate&#xD;
             in this investigation&#xD;
&#xD;
          -  Patients must be willing and able to comply with all follow-up requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with contraindication for cardiac surgery&#xD;
&#xD;
          -  Patients who are pregnant.&#xD;
&#xD;
          -  Patient is unwilling to or has an inability that reduces his mobility in order to&#xD;
             attend the required follow-up visits.&#xD;
&#xD;
          -  Patient has active endocarditis&#xD;
&#xD;
          -  Patient has had an acute preoperative neurological event defined as patient has not&#xD;
             returned to baseline 30 days prior to the planned valve implantation surgery.&#xD;
&#xD;
          -  Patient is undergoing renal dialysis.&#xD;
&#xD;
          -  Patient has a documented history of substance abuse within one year of enrollment or&#xD;
             is currently a prison inmate.&#xD;
&#xD;
          -  Patient has a documented thrombus in left atrium or left ventricle.&#xD;
&#xD;
          -  Patient had in the past mitral or tricuspid valve replacement.&#xD;
&#xD;
          -  Patient needs mitral and/or tricuspid valve replacement.&#xD;
&#xD;
          -  Patient has an Ejection Fraction &lt; 25%&#xD;
&#xD;
          -  Patient had the Trifecta™ valve implanted as part of this study, but then had the&#xD;
             device explanted&#xD;
&#xD;
          -  Preoperative evaluation indicates other significant cardiovascular abnormalities such&#xD;
             as aortic dissection or ventricular aneurysm.&#xD;
&#xD;
          -  Patient has a life expectancy less than two years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sven Lehmann</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitat Herzzentrum Leipzig</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitat Herzzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 7, 2010</study_first_submitted>
  <study_first_submitted_qc>December 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2010</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

